Ginkgo biloba extract EGb 761^® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.

ABSTRACT: Background: Patients who experienced an ischemic stroke are at risk for cognitive impairment. Quantified Ginkgo biloba extract EGb 761^® has been used to treat cognitive dysfunction, functional impairment and neuropsychiatric symptoms in mild cognitive impairment and dementia. Objectives: To assess the cognitive-related effects of EGb 761^® treatment in patients after acute ischemic stroke, as well as the feasibility of patient selection and outcome measures. Methods: We conducted a randomized, multicentric, open-label trial at 7 centers in China. Patients scoring 20 or lower on the National Institutes of Health Stroke Scale were enrolled between 7 and 14 days after stroke onset and randomly assigned to receive 240 mg per day of EGb 761^®

SUBMITTER: Cui M 

PROVIDER: S-EPMC10090660 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature